【レポートの概要（一部）】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Product Profiles
04.1 Soliris
04.2 Nplate
04.3 Revlimid
04.4 Vidaza
04.5 Promacta
04.6 Jakafi
04.7 Rituxan
05.Market Research Methodology
05.1 Market Research Process
05.2 Research Methodology
06.Introduction
07.Diseases Overview
07.1 ITP
07.1.1 Understanding the Disease
07.1.2 Epidemiology
07.1.3 Etiology
07.1.4 Pathophysiology
07.1.5 Management of Disease
07.2 MDS
07.2.1 Understanding the Disease
07.2.2 Epidemiology
07.2.3 Etiology
07.2.4 Pathophysiology
07.2.5 Management of Disease
07.3 MF
07.3.1 Understanding the Disease
07.3.2 Epidemiology
07.3.3 Etiology
07.3.4 Pathophysiology
07.3.5 Management of Disease
07.4 PNH
07.4.1 Understanding the Disease
07.4.2 Epidemiology
07.4.3 Etiology
07.4.4 Pathophysiology
07.4.5 Management of Disease
07.5 PV
07.5.1 Understanding the Disease
07.5.2 Epidemiology
07.5.3 Etiology
07.5.4 Pathophysiology
07.5.5 Management of Disease
07.6 Pipeline Analysis
07.7 Emerging Treatment Options
08.Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis
09.Market Segmentation by Indication Type
09.1.1 Market Size and Forecast for ITP
09.1.2 Market Size and Forecast for MDS
09.1.3 Market Size and Forecast for MF
09.1.4 Market Size and Forecast for PNH
09.1.5 Market Size and Forecast for PV
10.Geographical Segmentation
11.Buying Criteria
12.Market Growth Drivers
13.Drivers and their Impact
14.Market Challenges
15.Impact of Drivers and Challenges
16.Market Trends
17.Trends and their Impact
18.Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Market Share Analysis 2014
18.2.1 Competitive Assessment of Top Drugs
18.2.2 Alexion Pharmaceuticals
18.2.3 Amgen
18.2.4 Celgene
18.2.5 F. Hoffmann-La Roche
18.2.6 GlaxoSmithKline
18.2.7 Incyte
Other Prominent Vendors
19.Key Vendor Analysis
19.1 F. Hoffmann-La Roche Ltd.
19.1.1 Key Facts
19.1.2 Business Overview
19.1.3 Business Segmentation
19.1.4 Business Segmentation by Revenue 2012 and 2013
19.1.5 Sales by Geography
19.1.6 Business Strategy
19.1.7 Key Information
19.1.8 SWOT Analysis
19.2 Celgene
19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 Business Strategy
19.2.4 Business Segmentation by Revenue
19.2.5 Sales by Geography
19.2.6 Key Information
19.2.7 SWOT Analysis
19.3 Alexion
19.3.1 Key Facts
19.3.2 Business Overview
19.3.3 Geographical Segmentation by Revenue 2013
19.3.4 Business Strategy
19.3.5 Recent Developments
19.3.6 SWOT Analysis
19.4 Amgen
19.4.1 Key Facts
19.4.2 Business Overview
19.4.3 Business Segmentation by Revenue 2013
19.4.4 Product Portfolio by Revenue 2013
19.4.5 Business Segmentation by Revenue 2012 and 2013
19.4.6 Geographical Segmentation by Revenue 2013
19.4.7 Business Strategy
19.4.8 Recent Developments
19.4.9 SWOT Analysis
19.5 Incyte
19.5.1 Key Facts
19.5.2 Business Overview
19.5.3 Revenue Segmentation by 2013
19.5.4 Revenue Segmentation by 2012 and 2013
19.5.5 Geographical Segmentation
19.5.6 Business Strategy
19.5.7 Recent Developments
19.5.8 SWOT Analysis
19.6 GlaxoSmithKline
19.6.1 Key Facts
19.6.2 Business Overview
19.6.3 Business Segmentation
19.6.4 Business Segmentation by Revenue 2012 and 2013
19.6.5 Sales by Geography
19.6.6 Pipeline Products
19.6.7 Business Strategy
19.6.8 Key Information
19.6.9 SWOT Analysis
19.6.10 Strengths
19.6.11 Weaknesses
19.6.12 Opportunities
19.6.13 Threats
20.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Snapshot of ITP
Exhibit 3: Snapshot of MDS
Exhibit 4: Snapshot of MF
Exhibit 5: Snapshot of PNH
Exhibit 6: Snapshot of PV
Exhibit 7: Global Acquired Orphan Blood Diseases Therapeutics Market 2014-2019 (US$ million)
Exhibit 8: Global Acquired Orphan Blood Diseases Therapeutics Market Segmentation by Indication Type
Exhibit 9: Global Acquired Orphan Blood Diseases Therapeutics Market Revenue Comparison by Indication, 2014 and 2019 (US$ million)
Exhibit 10: Global Acquired Orphan Blood Diseases Therapeutics Market Percent Share by Indication, 2014 and 2019
Exhibit 11: Market Size and Forecast for ITP Market 2014-2019 (US$ million)
Exhibit 12: Market Size and Forecast for MDS Market 2014-2019 (US$ million)
Exhibit 13: Market Size and Forecast for MF Market 2014-2019 (US$ million)
Exhibit 14: Market Size and Forecast for PNH Market 2014-2019 (US$ million)
Exhibit 15: Market Size and Forecast for PV Market 2014-2019 (US$ million)
Exhibit 16: Geographical Segmentation of Global Acquired Orphan Blood Diseases Therapeutics Market in 2014
Exhibit 17: Marketing Exclusivity for Orphan Drugs in Some Regions
Exhibit 18: Revenue Comparison of Top Drugs for Acquired Orphan Blood Diseases Therapeutics market in 2013 (US$ million)
Exhibit 19: Revenue Comparison and YoY Growth for Soliris from 2012-2014 (US$ million)
Exhibit 20: Global Market Forecast for Soliris from 2014-2019 (US$ million)
Exhibit 21: Revenue Comparison and YoY Growth for Nplate from 2011-2013 (US$ million)
Exhibit 22: Revenue Comparison and YoY Growth for Revlimid from 2011-2013 (US$ million)
Exhibit 23: Revenue Comparison and YoY Growth for Vidaza from 2011-2013 (US$ million)
Exhibit 24: Revenue Comparison for Rituxan from 2012-2013 (US$ million)
Exhibit 25: Revenue Comparison and YoY Growth for Promacta 2011-2014 (US$ million)
Exhibit 26: Revenue Comparison for Jakafi from 2012-2013 (US$ million)
Exhibit 27: Business Segmentation of F. Hoffmann-La Roche Ltd. 2013
Exhibit 28: F. Hoffmann-La Roche Ltd.: Business Segmentation by Revenue 2012 and 2013
Exhibit 29: F. Hoffmann-La Roche Ltd.: Sales by Geography 2013 (Pharmaceuticals Division)
Exhibit 30: F. Hoffmann-La Roche Ltd.: Sales by Geography 2013 (Diagnostics Division)
Exhibit 31: Celgene: Business Segmentation by Revenue 2011-2013 (US$ million)
Exhibit 32: Celgene: Sales by Geography 2013
Exhibit 33: Alexion: Geographical Segmentation by Revenue 2013
Exhibit 34: Amgen: Business Segmentation by Revenue 2013
Exhibit 35: Amgen: Product Portfolio by Revenue 2013
Exhibit 36: Amgen: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 37: Amgen: Geographical Segmentation by Revenue 2013
Exhibit 38: Incyte Corporation: Revenue Segmentation by 2013 (US$ million)
Exhibit 39: Incyte Corporation: Revenue Segmentation by 2012 and 2013 (US$ million)
Exhibit 40: Incyte Corporation: Geographical Segmentation
Exhibit 41: GlaxoSmithKline: Business Segmentation 2013
Exhibit 42: GlaxoSmithKline: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 43: GlaxoSmithKline: Sales by Geography 2013
Exhibit 44: GlaxoSmithKline: Pipeline Products 2013
【レポート販売概要】
■ タイトル：後発性希少血液疾患治療薬の世界市場：PNH、ITP、PV、MF、MDS■ 英文：Global Acquired Orphan Blood Diseases Therapeutics Market 2015-2019
■ 発行日：2015年3月11日
■ 調査会社：Technavio
■ 商品コード：IRTNTR5409
■ 調査対象地域：グローバル
- 血管炎の疫学的予測（～2024）EpiCast Report: Vasculitis - Epidemiology Forecast to 2024 Summary Vasculitis is a group of heterogeneous disorders affecting persons of both sexes and all ages. These disorders are characterized by inflammation and necrosis of the blood vessels including the veins, arteries, and capillaries. There are various forms of vasculitis, and their clinical expressions may differ greatly in terms of sympt …
- 自動車用シール及びガスケットのグローバル市場（2014-2018）About Automotive Seals and Gaskets Automotive seals and gaskets assemblies check the passage of fluid between moving and stationary parts of the vehicle, respectively. Seals and gaskets serve multiple functions in a vehicle. They hold the necessary fluid, which may be liquid, gas, or vapor, in the working compartment, check the entry of dirt and other contaminations, and also prevent the release o …
- 頭頚部癌検査の世界市場：画像診断、内視鏡検査、歯科検査、生検About head and neck cancer Various types of malignant tumors grown in and around head and neck are collectively known as head and neck cancers. Most head and neck cancers usually begin in the squamous cells that line the moist mucosal surfaces inside the mouth, throat, and nose. This is often identified as squamous cell carcinoma. The cancers start in the oral cavity, nasal cavity, larynx, salivar …
- 軍用通信装置の世界市場：SATCOMシステム、レーダーシステム、無線システムAbout military communication Military communication includes electronic systems, products, and devices that are used for the transmission and reception of video, voice and data signals in military operations. The facilitation of communication has become an effective means for defense authorities to enhance the capabilities of their units. Also, the defense industry is embracing new communication t …
- 警告ラベルおよびシールの世界市場2016-2020About Warning Labels and Stickers A warning label is a label attached to a product or contained in a product's instruction manual, informing the client about the dangers associated with the use of the product. The label may also incorporate restrictions by the producer or seller on specific usages. The majority of the warning labels are used to confine common risks in claims against the product's …
- UFS（汎用フラッシュストレージ）の世界市場予測（～2023年）The universal flash storage market is estimated at USD 3.59 Billion in 2017 and is estimated to grow at a CAGR of 18.6% to reach USD 9.97 Billion by 2023. This growth is attributed to the increasing demand for electronic devices with faster performance and improved responsiveness, growing demand for wearable electronics, and rising adoption of high-speed data transfer technologies. Leading enterpr …
- モバイル広告支出の世界市場2015-2019About Mobile Ad Spending Mobile advertising (mobile ad) refers to the promotion activities done for marketing a product, service, or a brand by using mobile devices, such as cellphones and tablets, as a medium. Marketing intends to attract potential customers by delivering a message. Mobile ads are the paid form of non-personal announcement of an influential message. Mobile ad spending is calculat …
- ぶどう膜炎(Uveitis)：治療薬開発パイプライン動向（2015年上半期版）Uveitis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Uveitis - Pipeline Review, H1 2015’, provides an overview of the Uveitis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Uveitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administratio …
- クラウド型APIサービス（API as a Service）の世界市場About Application Program Interface as a Service In today’s era of business transformation from rational IT services to cloud hosting services, organizations leverage integrated business services through cloud computing platforms. At times, when greater levels of customization are required, API as a service is deployed to enhance cloud experience and also integrate applications in the cloud enviro …
- ポリオキシプロピレンビスフェノ-ルAの世界市場2015Propoxylated Bisphenol A (CAS 37353-75-6) Market Research Report 2015 aims at providing comprehensive data on Propoxylated Bisphenol A market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Propoxylated Bisphenol A description, covers its application areas, manufacturing methods, patterns. It captures Propoxylated Bisphenol A market trends, pays close …
- PETパッケージングの世界市場2015-2019About PET packaging PET is a polymer resin and is the most common type of plastic used in the packaging industry. It is used in the manufacturing of packaging products such as cups, bottles, vials, jars, and tubs, and other packaging materials for the food & beverages, healthcare and medical, cosmetics, and FMCG industries. Packaging plays a major role in attracting customers to purchase the produ …
- キャンプ用スリーピングバッグの世界市場2015-2019About Camping Sleeping Bags A sleeping bag is a bag used as a bed by those who engage in outdoor recreation activities such as camping, hiking, or climbing. It is similar to a blanket and used as a protection against wind, cold weather, and rain during outdoor expeditions. The camping sleeping bags vary in terms of size, insulation, and design. Two types of insulation materials are used to make ca …
- むずむず脚症候群（RLS/レストレスレッグス症候群）：グローバル臨床試験レビュー（2014年上半期）Restless Legs Syndrome Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Restless Legs Syndrome Global Clinical Trials Review, H1, 2014" provides data on the Restless Legs Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Restless Legs Syndrome. It includes an overview of the trial numbers and …
- 医療情報ソフトウェアの世界市場2015-2019About healthcare information software Healthcare information software is designed for capturing, storing, managing, and transmitting information related to the healthcare system. The software collects the data from the healthcare departments and other relevant sectors, analyzes the data, and improves quality. The solution converts the data into actionable advice, which in turn helps in decision ma …
- Wi-Fiホットスポットの世界市場：無線ホットスポットゲートウェイ、無線ホットスポットコントローラ、モバイルホットスポット端末The report on the Wi-Fi Hotspot market focuses on various Wi-Fi components, software solutions, services, verticals, and end users that are driving this market. NA, Europe, and APAC are the top three regions that hold the largest market share in the year 2015. The growth of mobile devices such as smartphones and tablets has fueled the demand for new wireless networking equipment that supports high …
